INTRODUCTION

The company has established modern Research and Development Facilities in the field of APIs and various Dosage forms. Elder’s Research and Development activities have earned recognition from the Department of Scientific & Industrial Research, Ministry of science & Technology, New Delhi. Our strength lies in the innovative chemistry-driven research, leading to the generation of non-infringing routs for APIs/Drug intermediates and Intellectual property.

Our objectives are:

Development of new products

Revision of existing products

Analytical Support and Customer assistance

Documentation

Patents

Custom Synthesis

Development of new products

Project assignment, which is a commercial proposal, made for the marketing stages.

Technical feasibility of the process. This takes into the account of chemistry, technology & safety. It is a decision taken by the technical staff.

Laboratory experiments, which leads to check out the synthesis route.

Laboratory process validation, optimization & experiments replication, which are carried out in order to verify reproducibility.

Revision of existing products

Quality improvement of final products

Problem arising from production

Safety & health considerations

Technical improvements.

Analytical Support

Method validation

New method developments

Impurity profiling, isolation, identification and synthesis

Customers Assistance

A prompt support & service is always allotted to customers in case of quality matters.

Documentation

Preparation of Development and Technology Transfer Dockets in line with regulatory approvals.

Patents

Evaluation of patents and non-infringement of process

Writing and filing of patents

Total fourteen patents have been filed. Four Indian patents along with the one international patent have been accepted till date.

Custom Synthesis

A complete package from gram scale to Kilogram Scale within stipulated time

Related documentation required by the customer

Presently working for the domestic as well as foreign companies for the APIS and the Intermediates with confidential agreements till scale up level.